ASSETS | |
---|
Current Assets | |
---|
Cash | | | N/A | N/A | 600.00K | 0.00 | |
Cash Equivalents | | | 290.00K | 4.62M | N/A | N/A | |
Marketable Securities | | | N/A | N/A | 235.60M | N/A | |
Receivables | | | 581.00K | 7.63M | 0.00 | 0.00 | |
Other Current Assets | | | 57.80M | 102.71M | 300.00K | N/A | |
Total Current Assets | | | 58.67M | 114.95M | 236.50M | 0.00 | |
|
Non-Current Assets | |
---|
PPE Net | | | 24.91M | 62.63M | N/A | N/A | |
Intangibles | | | 7.69M | 6.22M | N/A | N/A | |
Other Non-Current Assets | | | N/A | 0.00 | 0.00 | 700.00K | |
Total Non-Current Assets | | | 33.60M | 70.33M | 0.00 | N/A | |
|
TOTAL ASSETS | | | 92.28M | 185.29M | 236.50M | 700.00K | |
|
LIABILITIES | |
---|
Current Liabilities | |
---|
Short Term Debt | | | 32.75M | 197.54M | 0.00 | 0.00 | |
Accrued Expenses | | | 14.61M | 24.59M | 2.60M | 600.00K | |
Accounts Payable | | | 10.23M | 5.08M | 0.00 | N/A | |
Other Current Liabilities | | | 116.30M | 19.88M | 5.20M | 100.00K | |
Total Current Liabilities | | | 173.89M | 247.09M | 7.90M | 700.00K | |
|
Non-Current Liabilities | |
---|
Long Term Debt | | | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Liabilities | | | 1.07M | 1.45M | N/A | N/A | |
Total Non-Current Liabilities | | | 1.07M | 1.45M | 0.00 | 0.00 | |
|
TOTAL LIABILITIES | | | 174.96M | 248.54M | 7.90M | 700.00K | |
|
SHAREHOLDERS' EQUITY | |
---|
Retained Earnings | | | -106.70M | -88.21M | -6.90M | 0.00 | |
Additional Paid In Capital | | | 30.30M | 27.87M | 0.00 | 0.00 | |
Common Shares | | | 9.00K | 7.00K | 235.60M | 0.00 | |
Other Shareholders' Equity | | | -6.30M | -2.92M | N/A | N/A | |
Shares Outstanding | | | 3.49M | 2.88M | 31.60M | 27.70M | |
Tangible Book Value per Share | | | -25.89 | -24.15 | 7.24 | 0.00 | |
Total Shareholders' Equity | | | -82.69M | -63.25M | 228.70M | 0.00 | |
|
TOTAL LIABILITIES AND EQUITY | | | 92.28M | 185.29M | 236.50M | 700.00K | |
|
Statistics | |
---|
Current Ratio | | | 0.34 | 0.47 | 29.94 | N/A | |
Return On Assets (ROA) | | | -102.44% | -37.49% | 0.03% | N/A | |
Return On Equity (ROE) | | | N/A | N/A | 0.03% | N/A | |